
Beacon is a specialist pharmaceutical company based in the UK that focuses on niche opportunities within the hospital market. Current therapeutic areas of specialization include:- epilepsy, oncology, anaesthetics, infectious disease, dermatology and intensive care.
Beacon has several hospital products that are well established in its markets and is continuing to respond well to promotion by its team of Hospital Representatives.
Beacon is well positioned to partner with other companies to successfully commercialize products in a wide range of therapeutic areas and market settings. The company has a dedicated team committed to ensuring success, particularly in niche markets that are less attractive to multinational corporations.
Beacon has a two pronged strategy primarily aimed at the UK Hospital Market: -
1. Partnering with organisations to successfully commercialise products.
2. The acquisition of the non-strategic products from established pharmaceutical companies.
Dr Steven Short
Managing Director
Executive